MORGAN STANLEY

Position in APGE — Apogee Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$188,699,716

+$138,615,876 QoQ

Shares Held

1,421,681

+138.9% QoQ

Ownership

1.88%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#15

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. APGE ranks #15 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$188,699,716	1,421,681	+138.9%	Shares	Defined	2026-08-13
2026-03-31	$50,083,840	595,032	-33.2%	Shares	Defined	2026-05-15
2025-12-31	$67,197,123	890,264	+91.5%	Shares	Defined	2026-05-27
2025-09-30	$18,472,977	464,963	-2.1%	Shares	Defined	2026-05-27
2025-06-30	$20,616,305	474,702	-8.7%	Shares	Defined	2025-08-15
2025-03-31	$19,424,918	519,939	+148.1%	Shares	Defined	2025-05-15
2024-12-31	$9,491,888	209,534	-12.1%	Shares	Defined	2025-05-15
2024-09-30	$13,995,976	238,270	+1.5%	Shares	Defined	2025-05-14
2024-06-30	$9,238,589	234,780	+72.5%	Shares	Defined	2025-05-14
2024-03-31	$9,046,367	136,138	+101.1%	Shares	Defined	2024-10-17
2023-12-31	$1,891,507	67,699	+115.0%	Shares	Defined	2024-08-16
2023-09-30	$670,564	31,482	—	Shares	Defined	2023-11-15
No filing history on record for this holder in this stock.